Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morning versus evening tobramycin dosing in adults with cystic fibrosis
NL-OMON25851Recruiting
- Sponsor
- HagaZiekenhuis
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of tobramycin in cystic fibrosis (CF) and Pseudomonas aeruginosa pulmonary infection, sponsored by HagaZiekenhuis. Started Jun 2008; status: recruiting.
02
Drugs
tobramycin
03
Conditions
cystic fibrosis (CF)Pseudomonas aeruginosa pulmonary infection
Beyond the preview
Go deeper on NL-OMON25851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25851.